Published in J Neurochem on February 24, 2011
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging. JAMA Psychiatry (2014) 2.21
Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry (2012) 1.35
A mitochondrial bioenergetic etiology of disease. J Clin Invest (2013) 1.27
Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry (2012) 1.22
Brain transcriptional and epigenetic associations with autism. PLoS One (2012) 1.13
Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis (2013) 1.04
Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol (2014) 1.04
Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation (2012) 1.04
Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS One (2012) 1.00
Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry (2013) 0.99
Brain region-specific altered expression and association of mitochondria-related genes in autism. Mol Autism (2012) 0.96
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med (2015) 0.94
Evidence of neurodegeneration in autism spectrum disorder. Transl Neurodegener (2013) 0.94
Treatments for biomedical abnormalities associated with autism spectrum disorder. Front Pediatr (2014) 0.91
Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum. Acta Neuropathol Commun (2014) 0.90
Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome. Microb Ecol Health Dis (2015) 0.89
Neuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults. Acta Neuropathol Commun (2015) 0.87
The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders. OMICS (2015) 0.86
Recent updates in the treatment of neurodegenerative disorders using natural compounds. Evid Based Complement Alternat Med (2014) 0.86
Does microglial dysfunction play a role in autism and Rett syndrome? Neuron Glia Biol (2012) 0.84
Role of NAD(+), Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders. Int J Tryptophan Res (2013) 0.83
Elevated mitochondrial DNA copy number in peripheral blood cells is associated with childhood autism. BMC Psychiatry (2015) 0.83
Gestational exposure to a viral mimetic poly(i:C) results in long-lasting changes in mitochondrial function by leucocytes in the adult offspring. Mediators Inflamm (2013) 0.82
The neurogenic basic helix-loop-helix transcription factor NeuroD6 enhances mitochondrial biogenesis and bioenergetics to confer tolerance of neuronal PC12-NeuroD6 cells to the mitochondrial stressor rotenone. Exp Cell Res (2012) 0.81
Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala. Curr Neuropharmacol (2014) 0.81
Ubiquinol improves symptoms in children with autism. Oxid Med Cell Longev (2014) 0.81
Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD). Front Hum Neurosci (2013) 0.80
Purinergic signaling and energy homeostasis in psychiatric disorders. Curr Mol Med (2015) 0.79
Nanotechnology inspired tools for mitochondrial dysfunction related diseases. Adv Drug Deliv Rev (2016) 0.78
Reduced activity of protein kinase C in the frontal cortex of subjects with regressive autism: relationship with developmental abnormalities. Int J Biol Sci (2012) 0.77
Mitochondrial Dysfunction in Autism Spectrum Disorders. Autism Open Access (2016) 0.77
The molecular basis of cognitive deficits in pervasive developmental disorders. Learn Mem (2012) 0.77
Genetic Evidence for Elevated Pathogenicity of Mitochondrial DNA Heteroplasmy in Autism Spectrum Disorder. PLoS Genet (2016) 0.77
The BOLD signal and neurovascular coupling in autism. Dev Cogn Neurosci (2013) 0.76
Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy. J Autism Dev Disord (2012) 0.76
Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure. CNS Neurol Disord Drug Targets (2016) 0.76
Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms. Oxid Med Cell Longev (2017) 0.75
Potential serum biomarkers from a metabolomics study of autism. J Psychiatry Neurosci (2016) 0.75
Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects. Front Pharmacol (2017) 0.75
Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ (2009) 7.02
Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med (2000) 6.25
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
Autism spectrum disorders. Neuron (2000) 3.62
Can children with autism recover? If so, how? Neuropsychol Rev (2008) 3.40
Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med (2007) 3.18
Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci (2005) 3.01
Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr (2004) 3.00
Chromosomal disorders and autism. J Autism Dev Disord (1998) 2.62
Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain (2003) 2.59
Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci (2004) 2.56
Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol (2006) 2.49
Effects of age on brain volume and head circumference in autism. Neurology (2002) 2.44
The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol (2010) 2.42
The epidemiology of mitochondrial disorders--past, present and future. Biochim Biophys Acta (2004) 2.41
Autistic symptoms among children and young adults with isodicentric chromosome 15. Am J Med Genet (1998) 2.38
Neuropathological findings in autism. Brain (2004) 2.34
Histoanatomic observations of the brain in early infantile autism. Neurology (1985) 2.29
Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet (1998) 2.16
Course of behavioral change in autism: a retrospective study of high-IQ adolescents and adults. J Am Acad Child Adolesc Psychiatry (1996) 2.09
Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol (1996) 2.09
The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life (2002) 1.99
Oxidative stress in autism. Pathophysiology (2006) 1.95
Regression and word loss in autistic spectrum disorders. J Child Psychol Psychiatry (2004) 1.82
Mitochondrial dysfunction and psychiatric disorders. Neurochem Res (2008) 1.73
Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol (2005) 1.70
Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One (2008) 1.68
The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Neurochem (2009) 1.67
Mitochondrial mechanisms of neural cell apoptosis. J Neurochem (2004) 1.65
Prenatal stress and risk for autism. Neurosci Biobehav Rev (2008) 1.64
Parental report of the early development of children with regressive autism: the delays-plus-regression phenotype. Autism (2005) 1.57
Regression in autism: prevalence and associated factors in the CHARGE Study. Ambul Pediatr (2008) 1.56
Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med (1998) 1.55
Mitochondria as a pharmacological target. Pharmacol Rev (2002) 1.54
Brain development in autism: early overgrowth followed by premature arrest of growth. Ment Retard Dev Disabil Res Rev (2004) 1.52
Oxidative stress in autism. Altern Ther Health Med (2004) 1.52
Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr (2004) 1.49
Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci (2004) 1.44
Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev (2005) 1.43
Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem (2002) 1.42
Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol (2000) 1.41
Language and other regression: assessment and timing. J Autism Dev Disord (2003) 1.40
Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol (2002) 1.39
Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Biol Chem (2006) 1.37
The neuropathology of autism: a review. J Neuropathol Exp Neurol (2005) 1.34
Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids (2005) 1.34
Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol (2003) 1.30
Brain volume in autism. J Child Neurol (2001) 1.28
Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry (2008) 1.27
Large brains in autism: the challenge of pervasive abnormality. Neuroscientist (2005) 1.26
Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta (2009) 1.25
The neuropathology of autism. Brain Pathol (2007) 1.25
Use of the childhood autism rating scale with autistic adolescents and adults. J Am Acad Child Adolesc Psychiatry (1989) 1.24
Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med (2008) 1.22
Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry (1999) 1.22
Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci (2004) 1.21
A simplified model for mitochondrial ATP production. J Theor Biol (2006) 1.19
Relative carnitine deficiency in autism. J Autism Dev Disord (2004) 1.18
Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum (2009) 1.15
A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry (1993) 1.11
Autism: a mitochondrial disorder? Med Hypotheses (1998) 1.10
Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord (2006) 1.09
Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep (2009) 1.07
Mechanism of O2- generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems. Biochim Biophys Acta (1988) 1.04
Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic Biol Med (2009) 1.03
The neuropathology of autism: where do we stand? Neuropathol Appl Neurobiol (2007) 1.02
Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals. Life Sci (2009) 0.94
Targeting mitochondrial dysfunction in neurodegenerative disease: Part II. Expert Opin Ther Targets (2010) 0.94
Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochem Cell Biol (2009) 0.92
Fever plus mitochondrial disease could be risk factors for autistic regression. J Child Neurol (2009) 0.92
Autistic disorder in 2 children with mitochondrial disorders. J Child Neurol (2007) 0.91
Mitochondrial disease: beyond etiology unknown. J Pediatr Nurs (2000) 0.91
Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev (2003) 0.89
Mitochondrial enzymes in schizophrenia. J Mol Neurosci (2004) 0.89
Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clin Chim Acta (1994) 0.87
Impaired development of mitochondria plays a role in the central nervous system defects of fetal alcohol syndrome. Birth Defects Res A Clin Mol Teratol (2005) 0.85
Energetics of ATP-driven reverse electron transfer from cytochrome c to fumarate and from succinate to NAD in submitochondrial particles. Biochemistry (1984) 0.82
Imaging of autism: lessons from the past to guide studies in the future. Can J Psychiatry (1999) 0.81
Mitochondrial decay, a major cause of aging, can be delayed. J Alzheimers Dis (2004) 0.80
Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol (2005) 6.16
NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell (2008) 4.88
Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci (2008) 4.63
A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med (2012) 3.85
Elevated immune response in the brain of autistic patients. J Neuroimmunol (2009) 2.46
The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol (2010) 2.42
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A (2009) 2.20
Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging (2004) 2.18
Strategies for development of Dengue virus inhibitors. Antiviral Res (2010) 2.11
Oxidative stress in autism. Pathophysiology (2006) 1.95
Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis (2007) 1.86
Cholesterol biosynthesis modulation regulates dengue viral replication. Virology (2009) 1.64
A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother (2009) 1.59
Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci Lett (2006) 1.48
Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo. Biochemistry (2002) 1.48
Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol (2006) 1.44
Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci (2004) 1.44
CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat (2011) 1.43
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J (2008) 1.43
Dengue virus serotype infection specifies the activation of the unfolded protein response. Virol J (2007) 1.41
Effect of continuous ozone injection on performance and biomass accumulation of biofilters treating gaseous toluene. Appl Microbiol Biotechnol (2014) 1.39
Effect of continuous ozone injection on performance and biomass accumulation of biofilters treating gaseous toluene. Appl Microbiol Biotechnol (2014) 1.38
Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J Gen Virol (2006) 1.36
Targeted exome sequencing identified novel USH2A mutations in Usher syndrome families. PLoS One (2013) 1.28
Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res (2007) 1.27
The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic. EMBO J (2003) 1.22
Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer (2009) 1.22
Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome. J Biol Chem (2008) 1.22
Brain region-specific glutathione redox imbalance in autism. Neurochem Res (2012) 1.15
Mild cognitive impairment (MCI): a historical perspective. Int Psychogeriatr (2007) 1.15
Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol (2009) 1.12
MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract (2013) 1.12
A novel mutation in FRMD7 causing X-linked idiopathic congenital nystagmus in a large family. Mol Vis (2008) 1.12
Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. J Gen Virol (2008) 1.10
A missense mutation S228P in the CRYBB1 gene causes autosomal dominant congenital cataract. Chin Med J (Engl) (2007) 1.09
Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur J Biochem (2002) 1.08
BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects. J Neurosci Res (2010) 1.07
A novel frameshift mutation in FRMD7 causing X-linked idiopathic congenital nystagmus. Genet Test (2008) 1.06
Notch1 is involved in migration and invasion of human breast cancer cells. Oncol Rep (2011) 1.05
U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res (2011) 1.04
Effects of congenital cataract mutation R116H on alphaA-crystallin structure, function and stability. Biochim Biophys Acta (2010) 1.02
A high-throughput assay using dengue-1 virus-like particles for drug discovery. Antiviral Res (2010) 1.02
Slit2/Robo1 signaling in glioma migration and invasion. Neurosci Bull (2010) 1.02
Development of serum parameters panels for the early detection of pancreatic cancer. Int J Cancer (2013) 1.01
Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS One (2011) 1.01
Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A). Arch Biochem Biophys (2010) 1.00
Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism. J Pathol (2009) 1.00
Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis. Breast Cancer Res Treat (2008) 1.00
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. Clin Endocrinol (Oxf) (2014) 0.98
High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma. Tumour Biol (2012) 0.98
Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. J Neurochem (2009) 0.98
Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients. Breast Cancer Res Treat (2012) 0.97
Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma. Breast Cancer Res Treat (2010) 0.97
Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5. J Neurochem (2004) 0.97
Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways. Biochemistry (2006) 0.95
Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals. Life Sci (2009) 0.94
Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast. Mod Pathol (2008) 0.94
Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells. Neurochem Res (2011) 0.94
Humoral immune response to fibrillar beta-amyloid peptide. Biochemistry (2003) 0.93
A novel nonsense mutation in CRYBB1 associated with autosomal dominant congenital cataract. Mol Vis (2008) 0.92
Types and sociodemographic correlates of complementary and alternative medicine (CAM) use among people with epilepsy in Oman. Epilepsy Behav (2013) 0.92
The roles of two novel FBN1 gene mutations in the genotype-phenotype correlations of Marfan syndrome and ectopia lentis patients with marfanoid habitus. Genet Test (2008) 0.91
Hyperhomocysteinemia among Omani autistic children: a case-control study. Acta Biochim Pol (2011) 0.91
Clinicopathologic characteristics of pleomorphic carcinoma of the breast. Virchows Arch (2009) 0.90
Morphologic, phenotypic and functional characteristics of endothelial cells derived from human hepatic cavernous hemangioma. J Vasc Res (2006) 0.90
Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology (2009) 0.90
Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum. Acta Neuropathol Commun (2014) 0.90
Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome. J Alzheimers Dis (2008) 0.90
Glutathione redox imbalance in brain disorders. Curr Opin Clin Nutr Metab Care (2015) 0.90
Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial. Am J Ophthalmol (2011) 0.90
δEF1 down-regulates ER-α expression and confers tamoxifen resistance in breast cancer. PLoS One (2012) 0.89
Abnormal intracellular accumulation and extracellular Aβ deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders. PLoS One (2012) 0.89
Urea lesion formation in DNA as a consequence of 7,8-dihydro-8-oxoguanine oxidation and hydrolysis provides a potent source of point mutations. Chem Res Toxicol (2005) 0.89
Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice. J Neurosci Res (2012) 0.89
CYP-omega-hydroxylation-dependent metabolites of arachidonic acid inhibit the basolateral 10 pS chloride channel in the rat thick ascending limb. Kidney Int (2009) 0.88
Advances in the pathogenesis of Alzheimer's disease: focusing on tau-mediated neurodegeneration. Transl Neurodegener (2012) 0.88
Differences between the pattern of developmental abnormalities in autism associated with duplications 15q11.2-q13 and idiopathic autism. J Neuropathol Exp Neurol (2012) 0.88
Role of aquaporin-4 in the regulation of migration and invasion of human glioma cells. Int J Oncol (2011) 0.87
Synthesis and optical properties of SnO(2) nanorods. Nanotechnology (2008) 0.87
Intersectin1-s is involved in migration and invasion of human glioma cells. J Neurosci Res (2011) 0.87
Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation. PLoS One (2013) 0.87
Neuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults. Acta Neuropathol Commun (2015) 0.87
E-selectin and Sialyl Lewis X expression is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Int J Surg Pathol (2008) 0.86
Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase. Brain Res (2005) 0.86
Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial. J Ocul Pharmacol Ther (2011) 0.86
Alzheimer's Disease in Adults with Down Syndrome. Int Rev Res Ment Retard (2008) 0.86
Aquaporin-4 in glioma invasion and an analysis of molecular mechanisms. J Clin Neurosci (2010) 0.85
Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast. Breast Cancer Res Treat (2012) 0.85
Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors. Mol Cell Endocrinol (2005) 0.85
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial. Pituitary (2015) 0.85
Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2. Free Radic Biol Med (2008) 0.84
Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection. Acta Neuropathol (2013) 0.84
Ramified microglial cells promote astrogliogenesis and maintenance of neural stem cells through activation of Stat3 function. FASEB J (2008) 0.84
Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec (Hoboken) (2011) 0.84
Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance. Breast Cancer Res Treat (2012) 0.84
Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir. J Virol (2013) 0.84
Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma. Ai Zheng (2009) 0.83